Video by PCR via YouTube
Go to Source

Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.
The study provides evidence that stopping aspirin within 1 month for ticagrelor monotherapy is both non-inferior and superior to 12-month DAPT as for the 1-year composite outcome of death, myocardial infarction, stent thrombosis, stroke, and major bleeding.

Read more news from #TCT2023 here:
https://www.pcronline.com/News/Whats-new-on-PCRonline/2023/TCT/PCRonline-at-TCT-2023

Go to Source